Search

Displaying results 3701 - 3710 of 4860 in total
  1. Drug

    Maduramicin

    go.drugbank.com/drugs/DB11525
    ExperimentalVet approved

    It is a naturally occurring compound which was first isolated from the actinomycete, Actinomadura rubra.

  2. Drug

    Utidelone

    go.drugbank.com/drugs/DB17575
    Investigational

    [A257544,A257549] It is under investigation in clinical trials for various cancers.

  3. Drug

    RLYB212

    go.drugbank.com/drugs/DB17727
    Investigational

    It is currently being developed by Rallybio for the prevention of fetal and neonatal alloimmune thrombocytopenia.

  4. Drug

    SAR-439459

    go.drugbank.com/drugs/DB17864
    Investigational

    [A259862] Developed by Sanofi, it is being investigated for the treatment of cancers and Osteogenesis Imperfecta.

  5. Drug

    Efdoralprin alfa

    go.drugbank.com/drugs/DB18384
    Investigational

    [L54928] It is being investigated as a restorative therapy in adults with AATD emphysema.[L54928]

  6. Drug

    AB-201

    go.drugbank.com/drugs/DB18629
    Investigational

    [L48340] It is under investigation for the treatment of HER2-positive cancers, including breast and gastric carcinomas.

  7. Drug

    BRD-810

    go.drugbank.com/drugs/DB23607
    Experimental

    It is an inhibitor of the protein myeloid cell leukemia 1 (MCL1). [A274263]

  8. Drug

    Iodide I-123

    go.drugbank.com/drugs/DB09420
    ApprovedInvestigational

    Radioactive I-123 in particular is effective for this use as its half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and it has a reduced radiation burden as compared

  9. Drug

    Imetelstat

    go.drugbank.com/drugs/DB14909
    ApprovedInvestigational

    [A263973] It is used to treat anemia in patients with myelodysplastic syndromes (MDS), a group of hematologic disorders characterized by ineffective hematopoiesis, peripheral cytopenia, abnormal marrow

  10. Drug

    Lebrikizumab

    go.drugbank.com/drugs/DB11914
    ApprovedInvestigational

    [L51374] It binds to a different epitope compared [tralokinumab].